LXEO icon

Lexeo Therapeutics
LXEO

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$17.33
161% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Geulah Livshits
63% 1-yr LXEO win rate
13 Jan ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
57% 1-yr LXEO win rate
13 Jan ‘26 1 month ago
Raymond James
Raymond James
Chris Raymond
0% 1-yr LXEO win rate
18 Dec ‘25 2 months ago